BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30710135)

  • 1. Novel incretin receptor antibodies combat weight gain.
    Crunkhorn S
    Nat Rev Drug Discov; 2019 Feb; 18(2):95. PubMed ID: 30710135
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological antagonism of the incretin system protects against diet-induced obesity.
    Svendsen B; Capozzi ME; Nui J; Hannou SA; Finan B; Naylor J; Ravn P; D'Alessio DA; Campbell JE
    Mol Metab; 2020 Feb; 32():44-55. PubMed ID: 32029229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes.
    Cornell S
    J Clin Pharm Ther; 2012 Oct; 37(5):510-24. PubMed ID: 22436069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
    Drucker DJ; Nauck MA
    Lancet; 2006 Nov; 368(9548):1696-705. PubMed ID: 17098089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus.
    Nisal K; Kela R; Khunti K; Davies MJ
    BMC Med; 2012 Nov; 10():152. PubMed ID: 23198896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of insulin with incretin therapies for management of type 2 diabetes.
    Ahluwalia R; Vora J
    Diabetes Ther; 2011 Sep; 2(3):146-61. PubMed ID: 22127824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of incretin-based therapies--review of the scientific evidence.
    Drucker DJ; Sherman SI; Bergenstal RM; Buse JB
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2027-31. PubMed ID: 21734003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of incretin-based drugs in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Wang W; Gao Y; Chen D; Wang C; Feng X; Ran X
    Diabetes Res Clin Pract; 2017 Jul; 129():213-223. PubMed ID: 28552612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the science of incretin biology.
    Nauck MA
    Eur J Intern Med; 2009 Jul; 20 Suppl 2():S303-8. PubMed ID: 19580949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the science of incretin biology.
    Nauck MA
    Am J Med; 2009 Jun; 122(6 Suppl):S3-S10. PubMed ID: 19464426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus.
    Campbell RK
    Clin Ther; 2011 May; 33(5):511-27. PubMed ID: 21665040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
    Jalewa J; Sharma MK; Hölscher C
    J Neurochem; 2016 Oct; 139(1):55-67. PubMed ID: 27412483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists.
    Gasbjerg LS; Bergmann NC; Stensen S; Christensen MB; Rosenkilde MM; Holst JJ; Nauck M; Knop FK
    Peptides; 2020 Mar; 125():170183. PubMed ID: 31693916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incretin Hormones and Type 2 Diabetes-Mechanistic Insights and Therapeutic Approaches.
    Boer GA; Holst JJ
    Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33339298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in incretin-based therapies: the current state of the field.
    Robertson C
    J Am Acad Nurse Pract; 2009 Nov; 21 Suppl 1():631-41. PubMed ID: 19900194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin based therapies for type 2 diabetes mellitus.
    Ghosh S; Collier A; Elhadd T; Malik I
    J Indian Med Assoc; 2008 Jun; 106(6):373-4, 383, 388. PubMed ID: 18839649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intersection of safety and adherence: new incretin-based therapies in patients with type 2 diabetes mellitus.
    Zarowitz BJ; Conner C
    Pharmacotherapy; 2009 Dec; 29(12 Pt 2):55S-67S. PubMed ID: 19947817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin-based therapy and type 2 diabetes.
    Hare KJ; Knop FK
    Vitam Horm; 2010; 84():389-413. PubMed ID: 21094909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin-based therapy of type 2 diabetes mellitus.
    Knop FK; Vilsbøll T; Holst JJ
    Curr Protein Pept Sci; 2009 Feb; 10(1):46-55. PubMed ID: 19275672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin hormones: Their role in health and disease.
    Nauck MA; Meier JJ
    Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.